- Full Year 2024 Astellas Pharma Inc Earnings Presentation TranscriptApr 25, 2024
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 21, 2024
- Q3 2024 Astellas Pharma Inc Earnings Presentation TranscriptFeb 05, 2024
- Astellas Pharma Inc IZERVAY Briefing TranscriptNov 05, 2023
- Q2 2024 Astellas Pharma Inc Earnings Presentation TranscriptNov 01, 2023
- Q1 2024 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2023
- Astellas Pharma Inc to Acquire IVERIC bio Inc M&A Presentation TranscriptMay 01, 2023
- Full Year 2023 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2023
- Astellas Pharma Inc Corporate- wide Digital Transformation Driven by Analytics Briefing TranscriptMar 27, 2023
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 17, 2023
- Q3 2023 Astellas Pharma Inc Earnings Presentation TranscriptFeb 06, 2023
- Astellas Pharma Inc R&D Briefing TranscriptDec 09, 2022
- Q2 2023 Astellas Pharma Inc Earnings Presentation TranscriptOct 31, 2022
- Astellas Pharma Inc Fezolinetant Briefing TranscriptOct 17, 2022
- Q1 2023 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2022
- Full Year 2022 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2022
- Astellas Pharma Inc R&D Meeting TranscriptMar 09, 2022
- Astellas Pharma Inc Sustainability Briefing TranscriptFeb 28, 2022
- Q3 2022 Astellas Pharma Inc Earnings Presentation TranscriptFeb 02, 2022
- Astellas Pharma Inc R&D Meeting TranscriptDec 07, 2021
- Q2 2022 Astellas Pharma Inc Earnings Presentation TranscriptOct 29, 2021
- Q1 2022 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2021円1739 (-8.81%)Earnings
- Astellas Pharma Inc. Corporate Strategic Plan Presentation TranscriptMay 26, 2021
- Full Year 2021 Astellas Pharma Inc Earnings Call TranscriptApr 27, 2021円1597 (-3.15%)Earnings
- Q3 2021 Astellas Pharma Inc Earnings Call TranscriptJan 29, 2021円1692.5 (-0.88%)Earnings
- Astellas Pharma Inc R&D Meeting TranscriptDec 10, 2020
- Q2 2021 Astellas Pharma Inc Earnings Presentation TranscriptOct 30, 2020
- Q1 2021 Astellas Pharma Inc Earnings Call TranscriptAug 04, 2020円1709 (-0.32%)Earnings
- Full Year 2020 Astellas Pharma Inc Earnings Call TranscriptMay 18, 2020円1721.5 (-0.38%)Earnings
- Q3 2020 Astellas Pharma Inc Earnings Call TranscriptJan 31, 2020円1950.5 (+2.39%)Earnings
- Astellas Pharma Inc Approaches to Immuno-Oncology R&D Conference Call TranscriptDec 10, 2019
- Astellas Pharma Inc Acquisition of Audentes Therapeutics Inc Call TranscriptDec 03, 2019
- Q2 2020 Astellas Pharma Inc Earnings Call TranscriptOct 31, 2019円1858.5 (+0.87%)Earnings
- Astellas Pharma Inc Enfortumab Vedotin Call TranscriptOct 01, 2019
- Q1 2020 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2019円1527 (+0.23%)Earnings
- Full Year 2019 Astellas Pharma Inc Earnings Call TranscriptApr 25, 2019円1481.5 (-2.53%)Earnings
Q2 2020 Astellas Pharma Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen. Today, thank you very much for coming to our meeting for us to announce our second-quarter financial results. So let me go into my presentation without any further ado. Page 2 is a cautionary statement, as [already] explained, so let me skip. Page 3, this is the agenda for today in my presentation.
Page 4, this slide gives you an overview of the consolidated results on a core basis. Revenues increased to JPY650.5 billion, up 0.5% year-on-year. Core operating profits rose to JPY168 billion, up 8.9% year-on-year. Core profits were JPY135.9 billion, up 8.9% year-on-year. Core EPS rose by 12.8%.
Next page please. This slide shows the year-on-year revenue analysis. The top, JPY647.1 billion, and the four lines beneath. As you can see there, sales of major products increased year-on-year. XTANDI, XOSPATA, mirabegron, global products had increased sales and Evenity launched in March and new product in Japan contributed to increased sales.
On the other hand, in the United States
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)